Cargando…
Phosphoglycerate mutase 2 is elevated in serum of patients with heart failure and correlates with the disease severity and patient’s prognosis
BACKGROUND: Heart failure (HF) is a serious and advanced stage of various cardiac diseases with high mortality and rehospitalization rates. Phosphoglycerate mutase 2 (PGAM2) overexpression was identified in the serum of patients with HF. MATERIAL/METHODS: One hundred and fifty-three cases of HF were...
Autores principales: | Li, Min, Gao, Xiaoyuan, Wang, Huiyun, Zhang, Mingli, Li, Xiaoying, Wang, Shuya, Wang, Shaoqin, Cao, Chongfeng, Li, Ying, Su, Guohai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359905/ https://www.ncbi.nlm.nih.gov/pubmed/34435138 http://dx.doi.org/10.1515/med-2021-0324 |
Ejemplares similares
-
Development of Anthraquinone Analogues as Phosphoglycerate Mutase 1 Inhibitors
por: Huang, Ke, et al.
Publicado: (2019) -
Identification of Epigallocatechin-3- Gallate as an Inhibitor of Phosphoglycerate Mutase 1
por: Li, Xiaoguang, et al.
Publicado: (2017) -
Sumoylation-deficient phosphoglycerate mutase 2 impairs myogenic differentiation
por: Zhang, Yi, et al.
Publicado: (2022) -
Structure–activity relationship of ipglycermide binding to phosphoglycerate mutases
por: Wiedmann, Mareike, et al.
Publicado: (2021) -
Phosphoglycerate Mutase Cooperates with Chk1 Kinase to Regulate Glycolysis
por: Mikawa, Takumi, et al.
Publicado: (2020)